Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01940172
Title Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors TetraLogic Pharmaceuticals
Age Groups: adult
Covered Countries USA

No variant requirements are available.